PA452
PA452 is a selective RXR antagonist that inhibits retinoic acid-mediated modulation of Th1/Th2 cell differentiation. This small molecule is a valuable research tool for studying RXR function in immunology, inflammation, and autoimmune disease models, applicable in both in vitro and in vivo experimental systems.
Product Specifications
CAS Number
457657-34-0
Product Name Alternative
PA452, PA-452, PA 452, RAR, RAR/RXR, Retinoid Receptor, RetinoidReceptor, RXR
Field of Research
Metabolism Research
Purity
96.76% (May vary between batches)
Solubility
DMSO:36 mg/mL (81.89 mM) ; Ethanol:4.4 mg/mL (10.01 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.55 mM)
Smiles
CCCCCCOc1cc2c (cc1N (C) c1ncc (cn1) C (O) =O) C (C) (C) CCC2 (C) C
Molecular Formula
C26H37N3O3
Molecular Weight
439.59
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1410215-01 0.02 mg (E-Coli)
Recombinant Staphylococcus epidermidis Putative septation protein spoVG (spoVG)
Sign In for Pricing
View Details MBS1410215-02 0.1 mg (E-Coli)
Recombinant Staphylococcus epidermidis Putative septation protein spoVG (spoVG)
Sign In for Pricing
View Details